The role of the gun industry in America’s gun violence epidemic.
Do you have questions about guns or gun violence in America? This is Ask The Trace, a question series driven by readers.
The National Rifle Association is one of the most powerful special interest groups in America. We’re investigating how it spends its money.
A newsletter spotlighting the people, policies, and programs grappling with the gun violence crisis.
Our team, our mission, our partners, and more. Plus: How to contact us.
We report stories that would go untold. Generous readers sustain our work.
Sign up now to get our latest stories and eye-opening briefings.
The Trajectory
Community leaders say it’s not attributable to a single initiative, but rather a tapestry of collaborative, mostly grassroots efforts.
Mass Shooting
Lawmakers wanted to help more victims by defining “mass shootings,” but they came up short.
Harnessing the state’s red flag law, Suffolk County has become a leader in the use of extreme risk protection orders. Its process could be a model for police nationwide.
Year in Review
Highlights from a year on the gun violence beat.
Concealed Carry
Places of worship must now choose whether to let congregants carry firearms while attending services. The change comes amid an increase in bias incidents motivated by the Israel-Hamas war.
The tragedy, in which 10 Black people were killed, was a missed opportunity to confront the legacy of segregation, community members say.
Health Care
A 2019 Trace partnership with THE CITY and Measure of America found that shooting victims in the borough were more likely to die than anywhere else in the city.
Ask The Trace
Laws to expand the technology's use have passed in three states and the District of Columbia. But some are questioning its effectiveness.
Law Enforcement
The city is ramping up its efforts to collect genetic material. But the absence of oversight alarms forensic and legal experts.
How We Fix This
The city has launched an ambitious program to collect DNA from every gun recovered by police. But questions remain about effectiveness, and cost.